Courtney D Fitzhugh

Summary

Affiliation: National Institutes of Health
Country: USA

Publications

  1. pmc Cardiopulmonary complications leading to premature deaths in adult patients with sickle cell disease
    Courtney D Fitzhugh
    Molecular and Clinical Hematology Branch, National Heart, Lung, and Blood Institute and National Institute of Diabetes, Digestive, and Kidney Diseases NIH, 9000 Rockville Pike, Bethesda, MD 20892, USA
    Am J Hematol 85:36-40. 2010
  2. doi request reprint Nonmyeloablative HLA-matched sibling allogeneic hematopoietic stem cell transplantation for severe sickle cell phenotype
    Matthew M Hsieh
    Molecular and Clinical Hematology Branch, National Institute of Diabetes and Digestive and Kidney Diseases, Bethesda, Maryland2National Heart, Lung, and Blood Institute, Bethesda, Maryland
    JAMA 312:48-56. 2014
  3. pmc Hematopoietic stem cell transplantation for patients with sickle cell disease: progress and future directions
    Courtney D Fitzhugh
    9000 Rockville Pike, Building 10 9N112, Bethesda, MD 20892, USA
    Hematol Oncol Clin North Am 28:1171-85. 2014
  4. pmc Infusion of hemolyzed red blood cells within peripheral blood stem cell grafts in patients with and without sickle cell disease
    Courtney D Fitzhugh
    Molecular and Clinical Hematology Branch, National Heart, Lung, and Blood Institute NHLBI National Institute of Diabetes and Digestive and Kidney Diseases NIDDK, National Institutes of Health NIH, Bethesda, MD 20892, USA
    Blood 119:5671-3. 2012
  5. pmc Granulocyte colony-stimulating factor (G-CSF) administration in individuals with sickle cell disease: time for a moratorium?
    Courtney D Fitzhugh
    Molecular and Clinical Hematology Branch, National Institute of Diabetes, Digestive and Kidney Diseases and National Heart, Lung and Blood Institute, National Institutes of Health, NIH, Bethesda, Maryland, USA
    Cytotherapy 11:464-71. 2009
  6. pmc Allogeneic hematopoietic stem-cell transplantation for sickle cell disease
    Matthew M Hsieh
    Molecular and Clinical Hematology Branch, National Institute of Diabetes and Digestive and Kidney Diseases, Bethesda, MD, USA
    N Engl J Med 361:2309-17. 2009

Collaborators

  • Marilyn J Telen
  • Gregory J Kato
  • Matthew M Hsieh
  • Jonathan D Powell
  • Griffin P Rodgers
  • John F Tisdale
  • R Patrick Weitzel
  • Wynona A Coles
  • Mary E Link
  • Xiongce Zhao
  • M Beth Link
  • Elizabeth M Kang
  • Charles D Bolan
  • Richard W Childs
  • Roger Kurlander

Detail Information

Publications6

  1. pmc Cardiopulmonary complications leading to premature deaths in adult patients with sickle cell disease
    Courtney D Fitzhugh
    Molecular and Clinical Hematology Branch, National Heart, Lung, and Blood Institute and National Institute of Diabetes, Digestive, and Kidney Diseases NIH, 9000 Rockville Pike, Bethesda, MD 20892, USA
    Am J Hematol 85:36-40. 2010
    ..Further, arrhythmia leading to premature death is under-recognized in SCD and warrants further investigation...
  2. doi request reprint Nonmyeloablative HLA-matched sibling allogeneic hematopoietic stem cell transplantation for severe sickle cell phenotype
    Matthew M Hsieh
    Molecular and Clinical Hematology Branch, National Institute of Diabetes and Digestive and Kidney Diseases, Bethesda, Maryland2National Heart, Lung, and Blood Institute, Bethesda, Maryland
    JAMA 312:48-56. 2014
    ..Nonmyeloablative transplantation has been attempted with degrees of preparative regimen intensity, but graft rejection and graft-vs-host disease remain significant...
  3. pmc Hematopoietic stem cell transplantation for patients with sickle cell disease: progress and future directions
    Courtney D Fitzhugh
    9000 Rockville Pike, Building 10 9N112, Bethesda, MD 20892, USA
    Hematol Oncol Clin North Am 28:1171-85. 2014
    ..Haploidentical transplants have less GVHD, but improvements are needed to increase the low engraftment rate. The decision to use unrelated cord blood units or haploidentical donors depends on institutional expertise. ..
  4. pmc Infusion of hemolyzed red blood cells within peripheral blood stem cell grafts in patients with and without sickle cell disease
    Courtney D Fitzhugh
    Molecular and Clinical Hematology Branch, National Heart, Lung, and Blood Institute NHLBI National Institute of Diabetes and Digestive and Kidney Diseases NIDDK, National Institutes of Health NIH, Bethesda, MD 20892, USA
    Blood 119:5671-3. 2012
    ..Our data do not support free hemoglobin as a significant contributor to toxicity associated with PBSC infusions. This study was registered at clinicaltrials.gov (NCT00631787)...
  5. pmc Granulocyte colony-stimulating factor (G-CSF) administration in individuals with sickle cell disease: time for a moratorium?
    Courtney D Fitzhugh
    Molecular and Clinical Hematology Branch, National Institute of Diabetes, Digestive and Kidney Diseases and National Heart, Lung and Blood Institute, National Institutes of Health, NIH, Bethesda, Maryland, USA
    Cytotherapy 11:464-71. 2009
    ..Unless further data demonstrate safety, routine usage of G-CSF in individuals with SCD should be avoided...
  6. pmc Allogeneic hematopoietic stem-cell transplantation for sickle cell disease
    Matthew M Hsieh
    Molecular and Clinical Hematology Branch, National Institute of Diabetes and Digestive and Kidney Diseases, Bethesda, MD, USA
    N Engl J Med 361:2309-17. 2009
    ..Graft rejection and graft-versus-host disease (GVHD) are additional barriers to its success. We performed nonmyeloablative stem-cell transplantation in adults with sickle cell disease...